{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T18:55:07Z","timestamp":1758048907191,"version":"3.44.0"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81870128"],"award-info":[{"award-number":["81870128"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010843","name":"Guangzhou Science, Technology and Innovation Commission","doi-asserted-by":"publisher","award":["201804010301"],"award-info":[{"award-number":["201804010301"]}],"id":[{"id":"10.13039\/501100010843","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.bbrc.2021.09.029","type":"journal-article","created":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T01:11:29Z","timestamp":1631841089000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Selective elimination of CML stem\/progenitor cells by picropodophyllin in\u00a0vitro and in\u00a0vivo is associated with p53 activation"],"prefix":"10.1016","volume":"579","author":[{"given":"Fenfang","family":"Liao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qingqing","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiaqi","family":"Wen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangjie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weizhang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2021.09.029_bib1","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1038\/s41375-019-0490-0","article-title":"Chronic myeloid leukemia stem cells","volume":"33","author":"Houshmand","year":"2019","journal-title":"Leukemia"},{"key":"10.1016\/j.bbrc.2021.09.029_bib2","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1172\/JCI35721","article-title":"Human chronic myeloid leukemia stem cells are insensitive to imatinib despite inhibition of BCR-ABL activity","volume":"121","author":"Corbin","year":"2011","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.bbrc.2021.09.029_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19113533","article-title":"Anticancer activity of natural compounds from plant and marine environment","volume":"19","author":"Lichota","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbrc.2021.09.029_bib4","doi-asserted-by":"crossref","first-page":"140","DOI":"10.3109\/0284186X.2015.1049290","article-title":"A\u00a0novel oral insulin-like growth factor-1 receptor pathway modulator and its implications for patients with non-small cell lung carcinoma: A phase I clinical trial","volume":"55","author":"Ekman","year":"2016","journal-title":"Acta Oncol."},{"key":"10.1016\/j.bbrc.2021.09.029_bib5","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1182\/blood-2005-01-0293","article-title":"Inhibiting the IGF-1 receptor tyrosine kinase with the cyclolignan PPP: an in\u00a0vitro and in\u00a0vivo study in the 5T33MM mouse model","volume":"107","author":"Menu","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2021.09.029_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbrc.2013.08.050","article-title":"Picropodophyllin inhibits tumor growth of human nasopharyngeal carcinoma in a mouse model","volume":"439","author":"Yin","year":"2013","journal-title":"Biochem Bioph Res Co"},{"key":"10.1016\/j.bbrc.2021.09.029_bib7","article-title":"IGF1 receptor inhibition amplifies the effects of cancer drugs by autophagy and immune-dependent mechanisms","volume":"9","author":"Wu","year":"2021","journal-title":"J\u00a0Immunother Cancer"},{"key":"10.1016\/j.bbrc.2021.09.029_bib8","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.3892\/ol.2014.2484","article-title":"Picropodophyllin and sorafenib synergistically suppress the proliferation and motility of hepatocellular carcinoma cells","volume":"8","author":"Tomizawa","year":"2014","journal-title":"Oncol Lett"},{"key":"10.1016\/j.bbrc.2021.09.029_bib9","doi-asserted-by":"crossref","DOI":"10.1172\/JCI136098","article-title":"N-cadherin upregulation mediates adaptive radioresistance in glioblastoma","volume":"131","author":"Osuka","year":"2021","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.bbrc.2021.09.029_bib10","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.3892\/ijo.2011.1281","article-title":"Multiple antitumor effects of picropodophyllin in colon carcinoma cell lines: clinical implications","volume":"40","author":"Feng","year":"2012","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbrc.2021.09.029_bib11","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2407-13-521","article-title":"The association of TP53 mutations with the resistance of colorectal carcinoma to the insulin-like growth factor-1 receptor inhibitor picropodophyllin","volume":"13","author":"Wang","year":"2013","journal-title":"BMC Canc."},{"key":"10.1016\/j.bbrc.2021.09.029_bib12","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1158\/1535-7163.MCT-13-0091","article-title":"Alternative cytotoxic effects of the postulated IGF-IR inhibitor picropodophyllin in\u00a0vitro","volume":"12","author":"Wu","year":"2013","journal-title":"Mol. Canc. Therapeut."},{"key":"10.1016\/j.bbrc.2021.09.029_bib13","doi-asserted-by":"crossref","first-page":"8379","DOI":"10.18632\/oncotarget.2292","article-title":"Picropodophyllin causes mitotic arrest and catastrophe by depolymerizing microtubules via Insulin-like growth factor-1 receptor-independent mechanism","volume":"5","author":"Waraky","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbrc.2021.09.029_bib14","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.leukres.2015.07.008","article-title":"Silencing of miR-21 sensitizes CML CD34+ stem\/progenitor cells to imatinib-induced apoptosis by blocking PI3K\/AKT pathway","volume":"39","author":"Wang","year":"2015","journal-title":"Leuk. Res."},{"key":"10.1016\/j.bbrc.2021.09.029_bib15","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ccr.2010.03.011","article-title":"Effective targeting of quiescent chronic myelogenous leukemia stem cells by histone deacetylase inhibitors in combination with imatinib mesylate","volume":"17","author":"Zhang","year":"2010","journal-title":"Canc. Cell"},{"key":"10.1016\/j.bbrc.2021.09.029_bib16","first-page":"512","article-title":"Establishment of CML chimeric model by GFP\/SCL-tTA\/Bcr-abl transgenic mice","volume":"32","author":"Liao","year":"2016","journal-title":"J.Guangdong.Pharm. Univ."},{"key":"10.1016\/j.bbrc.2021.09.029_bib17","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.bbrc.2014.10.107","article-title":"Targeting miR-21 sensitizes Ph+ ALL Sup-b15 cells to imatinib-induced apoptosis through upregulation of PTEN","volume":"454","author":"Wang","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2021.09.029_bib18","first-page":"241","article-title":"Effects of picropodophyllin on Ph+ acute lymphoblastic leukemia Sup-B15 cells and its underlying mechanisms","volume":"33","author":"Chen","year":"2017","journal-title":"J.Guangdong.Pharm. Univ."},{"key":"10.1016\/j.bbrc.2021.09.029_bib19","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ccr.2011.12.020","article-title":"Activation of p53 by SIRT1 inhibition enhances elimination of CML leukemia stem cells in combination with imatinib","volume":"21","author":"Li","year":"2012","journal-title":"Canc. Cell"},{"year":"2021","series-title":"ANP32B-mediated Repression of P53 Contributes to Maintenance of Normal and CML Stem Cells","author":"Yang","key":"10.1016\/j.bbrc.2021.09.029_bib20"},{"key":"10.1016\/j.bbrc.2021.09.029_bib21","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1158\/0008-5472.CAN-03-2522","article-title":"Cyclolignans as inhibitors of the insulin-like growth factor-1 receptor and malignant cell growth","volume":"64","author":"Girnita","year":"2004","journal-title":"Canc. Res."},{"key":"10.1016\/j.bbrc.2021.09.029_bib22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13045-015-0106-8","article-title":"IGF-IR determines the fates of BCR\/ABL leukemia","volume":"8","author":"Xie","year":"2015","journal-title":"J.\u00a0Hematol. Oncol."},{"key":"10.1016\/j.bbrc.2021.09.029_bib23","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s12032-015-0578-y","article-title":"A\u00a0phase I pilot study of the insulin-like growth factor 1 receptor pathway modulator AXL1717 in combination with gemcitabine HCl and carboplatin in previously untreated, locally advanced, or metastatic non-small cell lung cancer","volume":"32","author":"Holgersson","year":"2015","journal-title":"Med. Oncol."},{"key":"10.1016\/j.bbrc.2021.09.029_bib24","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1182\/blood-2011-01-331876","article-title":"IGF binding protein 2 supports the survival and cycling of hematopoietic stem cells","volume":"118","author":"Huynh","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2021.09.029_bib25","doi-asserted-by":"crossref","first-page":"3831","DOI":"10.1038\/onc.2008.8","article-title":"Bcr-Abl induces autocrine IGF-1 signaling","volume":"27","author":"Lakshmikuttyamma","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2021.09.029_bib26","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1002\/jcp.22561","article-title":"The p53 tumor suppressor protein regulates hematopoietic stem cell fate","volume":"226","author":"Asai","year":"2011","journal-title":"J.\u00a0Cell. Physiol."},{"key":"10.1016\/j.bbrc.2021.09.029_bib27","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1038\/nature01120","article-title":"The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults","volume":"419","author":"Zacchi","year":"2002","journal-title":"Nature"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X21013243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X21013243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T12:10:41Z","timestamp":1757765441000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X21013243"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":27,"alternative-id":["S0006291X21013243"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2021.09.029","relation":{},"ISSN":["0006-291X"],"issn-type":[{"type":"print","value":"0006-291X"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective elimination of CML stem\/progenitor cells by picropodophyllin in\u00a0vitro and in\u00a0vivo is associated with p53 activation","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2021.09.029","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}